Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells
Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells
نویسندگان: نصرت اله ضرغامی , یونس پیله ور سلطان احمدی , مهدی داداش پور , وحید شفیعی ایران نژاد
کلمات کلیدی: Metformin; curcumin; PLGA/
PEG; synergistic effect;
breast cancer
نشریه: 39930 , 0 , 0 , 2018
| نویسنده ثبت کننده مقاله |
نصرت اله ضرغامی |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
دانشکده پزشکی |
| کد مقاله |
61752 |
| عنوان فارسی مقاله |
Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells |
| عنوان لاتین مقاله |
Nano-encapsulated metformin-curcumin in PLGA/PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells |
| ناشر |
8 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
Artificial Cells, Nanomedicine, and Biotechnology |
| نوع مقاله |
Original Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
http://www.tandfonline.com/doi/abs/10.1080/21691401.2017.1347879?journalCode=ianb20 |
| The study was aimed at investigating the synergistic inhibitory effect of unique combinational regimen
of nanocapsulated Metformin (Met) and Curcumin (Cur) against T47D breast cancer cells. For this purpose,
Met and Cur were co-encapsulated in PEGylated PLGA nanoparticles (NPs) and evaluated for their
therapeutic efficacy. The morphology and dynamic light scattering (DLS) analyses were carried out to
optimize the nanoformulations. Drug release study was performed using dialysis method and then the
cytotoxic and inhibitory effect of individual and combined drugs on expression level of hTERT in T47D
breast cell line were evaluated using MTT assay and qPCR, respectively. The results showed that free
drugs and formulations exhibited a dose-dependent cytotoxicity against T47D cells and especially,
Met–Cur–PLGA/PEG NPs had more synergistic antiproliferative effect and significantly arrested the
growth of cancer cells than the other groups (p < .05). Real-time PCR results revealed that Cur, Met and
combination of Met–Cur in free and encapsulated forms inhibited hTERT gene expression. It was found
that Met–Cur–PLGA/PEG NPs in relative to free combination could further decline hTERT expression in
all concentration (p < .05). Taken together, our study demonstrated that Met–Cur–PLGA/PEG NPs based
combinational therapy holds promising potential towards the treatment of breast cancer. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| Nano-encapsulated metformin-curcumin in PLGA PEG inhibits synergistically growth and hTERT gene expression in human breast cancer cells.pdf | 1396/08/17 | 1323962 | دانلود |